Original Research

by

Peer-viewed studies and review articles on managed care.

ORIGINAL RESEARCH
Cost Effectiveness of the Insertion of Hydrogel Spacer in Men Treated With Radiation Therapy for Prostate Cancer
ABSTRACT  Purpose: The study examined the cost effectiveness of prostate cancer radiotherapy with and without the use of a hydrogel spacer. Design and Methodology: Retrospective data from Truven Health Analytics’ Commercial Claims and Medicare Supplemental database between 2012 and 2017 identified…
ORIGINAL RESEARCH
The COMPARE Study: Facility Costs Associated With Hysterectomy, Myomectomy, and the Sonata Procedure for Treatment of Uterine Fibroids
Abstract Purpose: The COMPARE study examined facility costs of sonography-guided transcervical fibroid ablation (TFA) using the Sonata System, hysterectomy, and myomectomy for the treatment of symptomatic uterine fibroids. Design and methodology: A facility-perspective cost analysis of hospital charge…
ORIGINAL RESEARCH
A Financial Analysis of New York City Start-up Health Plans and Reasons for Their Losses
Starting a health plan is difficult and success is certainly not guaranteed. Of three 2014 start-up health plans in New York City, Health Republic closed in 2015 and CareConnect closed on New Year’s
Eve 2017. Only Oscar remains, and it racked up cumulative losses of $235 million from 2014 to 2016.
ORIGINAL RESEARCH
Real-World Analysis of Dispensed International Units of Coagulation Factor VIII and Resultant Expenditures for Hemophilia A Patients: A Comparison Between Standard Half-Life and Extended Half-Life Products
Real-world data challenge assumptions regarding typical factor usage and expenditures associated with product switching in patients with hemophilia A. There were higher expenditures over two years on hemophilia A patients using extended half-life (EHL) versus standard half-life (SHL) products.